OVERVIEW

By 2026, the global market for breast biopsy devices is projected to hit USD 899.2 million, with a CAGR of 6.23% from 2021 to 2026. Growing incidences of breast cancer among women and growing breast cancer screening programs in different countries are major factors that drive market growth. Aside from that, market growth is being fuelled by a rise in reimbursement rate for image-guided biopsy in the United States, as well as an increase in demand for less invasive breast biopsy. COVID-19 will also be considered as a significant market contributor in the study.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Breast Biopsy Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Breast Biopsy Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Breast Biopsy Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Breast Biopsy Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Breast Biopsy Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Breast Biopsy Market ? By Type (Market Size ? & million/billion)
  • 8.1 Needle Breast Biopsy
  • 8.2 Open Surgical Breast Biopsy

• 9 Global Breast Biopsy Market - By Product
  • 9.1 Biopsy Needles
  • 9.2 Localization Wires
  • 9.3 Biopsy Tables
  • 9.4 Guidance Systems
  • 9.5 Others

• 10 Global Breast Biopsy Market - By Guidance
  • 10.1 Mammography-guided Stereotactic
  • 10.2 Ultrasound-guided
  • 10.3 Magnetic Resonance-guided
  • 10.4 Others

• 11 Global Breast Biopsy Market ? By Geography (Market Size ? & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global Breast Biopsy Market ? Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships

• 13 Global Breast Biopsy Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Argon Medical Devices
  • 13.3 Devicor Medical Products Inc.
  • 13.4 Hologic Inc.
  • 13.5 Becton, Dickinson and Company
  • 13.6 C.R. Bard, Inc.
  • 13.7 Cook Medical Incorporated
  • 13.8 Argon Medical Devices
  • 13.9 Galini SRL
  • 13.10 Ethicon Endo Surgery
  • 13.11 Encapsule Medical Devices LLC
  • 13.12 Company 11 & more

• 14 Global Breast Biopsy Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations